European Life Sciences Perspective: Corporate, Competition, IP, and Collaboration Trends in the European Life Sciences Market — Session 2

The life sciences industry is undergoing transformation across the globe and facing challenges and opportunities arising from the coronavirus (COVID-19) pandemic. In addition, the United Kingdom’s exit from the European Union is expected to bring significant changes for the industry in relation to issues including pharmaceutical and medical device regulation, antitrust and competition, and corporate transactions.